Serdemetan


CAS No. : 881202-45-5

(Synonyms: JNJ-26854165)

881202-45-5
Price and Availability of CAS No. : 881202-45-5
Size Price Stock
5mg $80 In-stock
10mg $130 In-stock
25mg $265 In-stock
50mg $450 In-stock
100mg $750 In-stock
200 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-12025
M.Wt: 328.41
Formula: C21H20N4
Purity: >98 %
Solubility: DMSO : 50 mg/mL (ultrasonic)
Introduction of 881202-45-5 :

Serdemetan (JNJ-26854165) is a potent anticancer agent with radiosensitizing activity. Serdemetan exhibits antiproliferative activity in various p53 wild-type tumor cells. Serdemetan also antagonizes the Mdm2-HIF1α axis leading to decreased levels of glycolytic enzymes[1][2][3]. In Vitro:Serdemetan (0.5-50 μM; 48-72 h) inhibits cell proliferation of H460, A549, p53-WT HCT116, p53-null HCT116 and HMEC-1 cells in a dose-dependent manner[1].
Serdemetan (0.25-5 μM; 48 h) triggers cell arrests in G2/M phase of A549 cells and H460 cells[1].
Serdemetan (0.5-10 μM; 48 h) increases expression of p53 and p21 in H460, A549 and p53-WT HCT116 cells[1].
Serdemetan (0.25-10 μM; 12-14 d) affects clonogenic survival in H460, A549 p53-WT HCT116 and p53-null HCT116 cells[1].
Serdemetan (0.25-5 μM; 12-14 d) increases radiation-induced clonogenic inhibition[1].
Serdemetan (5-20 μM; 4-24 h) inhibits neovessels formation and delays scratch wound repair of HMEC-1 cells[1].
In Vivo:Serdemetan (50 mg/kg) enhances radiation-induced growth delays in H460 and A549 xenograft tumors[1].

Your information is safe with us.